New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Evaluating sterile technologies via a 'bottom-line' approach

Using return on investment helps when considering isolators and restricted access barrier systems technologies.

Return on investment has long been a key factor in evaluating packaging systems, equipment, and materials. In a challenging economy, ROI seems an especially logical choice when evaluating isolators and restricted access barrier systems (RABS).

Shedding more light on the role of ROI in this decision-making process is a PharmaManufacturing.com article, “A Business Case for Isolation Technology.” The article cites a Jacobs study, saying, “Though capital costs for isolator-based facilities are higher upfront, they tend to be cheaper in the long run.” A table accompanying the story compares clean room, RABS, and isolator system base costs for various categories, including vial filling and syringe filling.

Discover Our Content Hub
Access Packaging World's free educational content library!
Unlock Learning Here
Discover Our Content Hub